TNFRSF1B and neoplasm: Blockade of TNFR2 signaling could markedly reduce the tumor‐infiltrating TNFR2+ Tregs in CRCs, whereas the number of tumor‐infiltrating IFN‐γ+CD8+ cytotoxic T lymphocytes were significantly increased.